SHIXIA HUANG to Mitogen-Activated Protein Kinases
This is a "connection" page, showing publications SHIXIA HUANG has written about Mitogen-Activated Protein Kinases.
Connection Strength
0.039
-
Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways. Br J Cancer. 2020 08; 123(4):568-579.
Score: 0.039
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.